文献速递类风湿关节炎

手部为主关节受累模式与早期类风湿关节炎治疗反应良好相关,多关节炎模式与反应不佳相关

Hand-dominant joint involvement pattern associates with favourable, and polyarthritis with unfavourable, treatment response to both csDMARDs and bDMARDs in early rheumatoid arthritis: a combined analysis of NORD-STAR and BeSt trials.
PubMed 文献 · Ann Rheum Dis · 2026-03-08

该研究基于NORD-STAR和BeSt两项随机对照试验的1250例未经治疗的早期类风湿关节炎患者数据,采用个体患者数据荟萃分析,评估关节受累模式亚组与csDMARDs及bDMARDs治疗反应的关系。结果显示手部为主模式患者治疗后CDAI显著更优,多关节炎模式患者结局更差,且两种药物在各亚组中疗效相似。

要点

  • 手部为主关节受累模式与csDMARDs和bDMARDs治疗后CDAI显著改善相关。
  • 多关节炎模式与治疗反应不佳相关,女性性别亦与更差CDAI相关。
  • csDMARDs与bDMARDs在各关节受累模式亚组中疗效相似。

核心结论

  • 在早期RA中,csDMARD和bDMARD治疗在手部为主关节受累模式患者中疾病活动度改善最大,在多关节炎模式患者中改善最小。

研究设计与样本

  • 基于NORD-STAR和BeSt两项随机对照试验的个体患者数据荟萃分析,纳入1250例未经治疗的早期RA患者,JIP亚组基于基线临床特征(主要为66/68关节 scheme)划分,采用混合模型分析至第48周。

临床怎么用

  • 基线关节受累模式(手部为主 vs 多关节炎)可用于早期RA治疗反应预判,手部为主模式预期反应较好。
  • 女性性别提示可能对治疗反应较差,需关注。
  • csDMARDs与bDMARDs在各关节受累模式亚组中疗效相似,选择药物时可不因关节模式而偏好某类。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the association between joint involvement pattern (JIP) subgroups and treatment responses to conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) and biological disease-modifying antirheumatic drugs (bDMARDs), and to compare the impact of JIP subgroups with other clinical parameters in treatment-naïve patients with early rheumatoid arthritis (RA). METHODS: An individual patient data meta-analysis was conducted using 2 randomised controlled trials, NOrdic Rheumatic Diseases Strategy Trials And Registries (NORD-STAR) and Behandel-Strategieën (BeSt), including 1250 treatment-naïve patients with early RA. JIP subgroup assignment was based on 4 previously identified subgroups defined by baseline clinical characteristics, primarily joint involvement in the 66/68 joint scheme. Treatment outcomes were measured using the longitudinal Clinical Disease Activity Index (CDAI) and other disease activity indices through week 48. Associations of the JIP subgroups and other clinical predictors were evaluated using a mixed-model analysis. RESULTS: Patients with a hand-dominant JIP (JIP-Hand) showed significantly better CDAI scores after treatment (Beta for CDAI = -1.4 [95% CI, -2.3 to -0.55]; p = .0016), whereas those with a polyarthritis pattern (JIP-Poly) exhibited worse outcomes (Beta = 0.95 [95% CI, 0.064-1.8]; p = .035). Female sex was also associated with worse CDAI scores (Beta = 1.2 [95% CI, 0.40-2.0]; p = .0031), whereas anticitrullinated protein antibodies did not show a significant association (Beta = 0.19 [95% CI, -0.69 to 1.1]; p = .67). When compared across groups, csDMARDs and combined bDMARDs were similarly effective in the respective JIP subgroups (interaction p > .10). CONCLUSIONS: In early RA, csDMARD and bDMARD treatments resulted in the greatest improvement in disease activity in JIP-Hand and the least improvement in JIP-Poly.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Nagafuchi Y, Maarseveen TD, Lend K, et al. Hand-dominant joint involvement pattern associates with favourable, and polyarthritis with unfavourable, treatment response to both csDMARDs and bDMARDs in early rheumatoid arthritis: a combined analysis of NORD-STAR and BeSt trials. Ann Rheum Dis. 2026. PMID: 41796486. doi:10.1016/j.ard.2026.02.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。